Meeting
2023 ASCO Quality Care Symposium
Potential out-of-pocket savings from hematology/oncology drugs for commercially insured patients via Mark Cuban Cost Plus Drug Company.
Authors
Jenny Jing Xiang
The University of Texas MD Anderson Cancer Center, Houston, TX
Jenny Jing Xiang, Xiudong Lei, Meng Li, Sharon H. Giordano, Ya-Chen Tina Shih, John Kent Lin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Cost and Cost-Effectiveness of Care
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 22)
DOI
10.1200/OP.2023.19.11_suppl.22
Abstract #
22
Poster Bd #
B5
Abstract Disclosures
Similar Posters
First Author: Nivedita Arora
Poster
2019 ASCO Quality Care Symposium
Impact of in-house specialty pharmacy on access to novel androgen axis inhibitors in men with advanced prostate cancer.
First Author: Nathan Handley
Poster
2019 ASCO Annual Meeting
Cost of oral cancer drugs: Trends in the United States Medicare population in 2013 and 2015.
First Author: Kira Rose-Madison Seiger
Poster
2013 ASCO Quality Care Symposium
Impact of Medicare Part D on out-of-pocket drug costs and utilization for patients with cancer.
First Author: Sheetal Mehta Kircher